Invesco Ltd. - SUCAMPO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SUCAMPO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$5,166,000
+5.8%
5,000,0000.0%0.00%0.0%
Q2 2017$4,881,000
-1.3%
5,000,0000.0%0.00%0.0%
Q1 2017$4,947,000
+16.1%
5,000,000
+25.0%
0.00%
+100.0%
Q4 2016$4,260,0004,000,0000.00%
Other shareholders
SUCAMPO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Southpaw Asset Management LP 19,125,000$18,683,00020.40%
Mohican Financial Management, LLC 1,500,000$1,464,0002.55%
Wellesley Asset Management 41,221$40,448,0002.09%
Context Capital Management, LLC 2,000,000$1,961,0001.40%
LINDEN ADVISORS LP 30,205,000$29,574,0001.25%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,341,000$30,675,0000.46%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 27,000,000$26,388,000,0000.43%
AQR Arbitrage LLC 34,950,000$34,295,0000.38%
WOLVERINE ASSET MANAGEMENT LLC 25,196,000$24,617,0000.31%
ADVENT CAPITAL MANAGEMENT /DE/ 4,308,000$4,220,0000.08%
View complete list of SUCAMPO PHARMACEUTICALS INC shareholders